Skip to main content
. Author manuscript; available in PMC: 2023 Aug 5.
Published in final edited form as: Circ Res. 2022 Jul 19;131(4):e84–e99. doi: 10.1161/CIRCRESAHA.122.320952

Table 2.

Baseline characteristics of participants in VITAL-CVD case-control substudy.

VITAL-CVD Controls Cases P-value
N 741 741
Age (years) * 69.5 (65.6, 74.9) 70.2 (65.7, 76.2) 1.7e-1
Women (%) 40.9 40.9 1.0
White (%) 87.2 88.5 1.0
Current smokers (%) 4.4 8.3 5.3e-3
BMI (kg/m2) * 26.6 (24.1, 30.1) 27.4 (24.4, 31.0) 8.0e-3
BMI categories 3.4e-1
  < 25 kg/m2 (%) 33.5 27.8
  25 to 29.9 kg/m2 (%) 41.1 42.2
  ≥ 30 kg/m2 (%) 25.4 30.0
HDL-C (mg/dL) * 50.0 (39.0, 63.0) 46.0 (38.0, 59.0) 3.7e-4
LDL-C (mg/dL) * 123.0 (101.2, 145.0) 119.0 (97.0, 145.0) 2.7e-1
Total-C (mg/dL) * 202.0 (176.0, 228.0) 196.0 (171.0, 227.0) 1.3e-1
Triglycerides (mg/dL) * 113.0 (86.5, 158.0) 121.0 (92.0, 177.0) 7.0e-3
hs-CRP (mg/L) * 1.7 (0.9, 3.9) 2.1 (1.1, 5.3) 1.5e-1
Main study intervention assignment (%) 48.9 51.0 2.0e-3
Physical activity * 14.6 (4.3, 30.0) 12.9 (3.0, 28.0) 4.1e-1
*

Median (IQR).

P-value for statistical test comparing controls vs. cases.

Data available only for 97 cases and 89 controls.

Abbreviations: BMI – body mass index; LDL-C – low density lipoprotein cholesterol; HDL-C – high density lipoprotein cholesterol; Total-C – total cholesterol; hs-CRP – high-sensitivity C-reactive protein.